Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

NCT01644591

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

NCT04661384

Conditions: Astrocytoma, Central Nervous System Neoplasms, Ependymoma, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)

NCT02362594

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Circulating Tumor DNA Collection From Patients With High Grade Gliomas

NCT05925218

Conditions: Glioma, High Grade Glioma, Neoplasms, +6 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy and TILs in the Treatment of Melanoma

NCT06961786

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: National Center for Cancer Immune Therapy Herlev Hospital, Copenhagen University Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

NCT02407405

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

NCT03152318

Conditions: Anaplastic Oligodendroglioma of Brain (Diagnosis), Astrocytoma, Brain Cancer, +28 more
Locations: Johns Hopkins University Medical Center Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas

NCT07448480

Conditions: Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +10 more
Locations: Blokhin's Russian Cancer Research Center Moscow, Russia

View Trial Details

Active, Not Recruiting

Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma

NCT04091750

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

Medstar Franklin Square Medical Center, Harry and Jeanette Weinberg Cancer Institute Baltimore, Maryland, United States

John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

NCT02658279

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: University of California, Los Angeles Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

University of Miami Miami, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View all 16 locations

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions